Individuals with ASD, individuals with ADHD, healthy subjects
Conditions
Interventions
rTMS on rTPJ (facilitation, inhibition)
rTMS on rTPJ (facilitation, inhibition)
rTMS on rTPJ (facilitation, inhibition, sham)
Sponsors
Showa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASD group 1) Subjects who had received a clinical diagnosis of ASD in outpatient units of the Showa University Karasuyama Hospital. 2) Aged 20-49 years-old, male and female 3) No serious comorbid psychiatric disorders or medical illness. 4) Capability of informed consent ADHD group 1) Subjects who had received a clinical diagnosis of ADHD in outpatient units of the Showa University Karasuyama Hospital. 2) Aged 20-49 years-old, male and female 3) No serious comorbid psychiatric disorders or medical illness. 4) Capability of informed consent Healthy group 1) Aged 20-49 years-old, male and female 2) No serious psychiatric disorders or medical illness. 3) Capability of informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects who are contraindicated for the use of MRI and TMS (e.g., implanted cardiac pacemaker, surgical aneurysm clips) 2) History of epilepsy, pregnancy, treatment with medication that can lower the seizure threshold. 3) Subjects who are judged as unsuitable for participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitrax | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychological tests including CANTAB | — |
Countries
Japan
Contacts
Public ContactJunya Fujino
Showa University Medical Institute of Developmental Disabilities Research
Outcome results
None listed